Man & Machine Episode 62: MIT News & Isomorphic Labs
Dec 9, 2021
The discussion kicks off with groundbreaking AI advancements, particularly a model that understands object relationships and creates images from text. They dive into how Isomorphic Labs, led by DeepMind's founder, aims to revolutionize drug discovery and healthcare. The importance of competition in tech innovation is highlighted, along with concerns about complacency among major players. Finally, the hosts express excitement and caution about the future of AI and its implications for precision medicine.
AI Snips
Chapters
Books
Transcript
Episode notes
AI Understands Object Relationships
- MIT developed a model that understands relationships between objects in a scene to generate images from text.
- This approach uses energy-based models to break down and recombine scene elements for flexible, novel image creation.
AI for Precision Medicine
- Isomorphic Labs aims to transform biology and drug discovery using AI, building on DeepMind's AlphaFold2 success.
- This could enable precision medicine by designing drugs tailored to individual genetic profiles and disease subtypes.
Gout Patient's Struggle Illustrates Need
- Dr. Ian Betts shared a patient story with severe, treatment-resistant gout.
- New AI-driven therapies might provide better tailored options improving quality of life.
